Finding the right ASX shares to hold over the next five years comes down to identifying businesses with strong growth drivers, scalable models, and the ability to keep compounding earnings over time.
While markets will inevitably have ups and downs, high-quality growth companies can often look through that noise.
Here are five ASX growth shares that could be worth buying and holding for the next five years.
Image source: Getty Images
Breville Group Ltd (ASX: BRG)
The first ASX growth share that could be a strong long-term pick is Breville.
Breville has built a premium global brand in kitchen appliances, with a focus on innovation and design. What makes the company particularly compelling is its international expansion.
A large portion of its revenue now comes from overseas markets, giving Breville exposure to a much larger opportunity than the domestic market alone. Combined with its leadership position in the thriving coffee market, this leaves it well-placed for sustainable growth.
Life360 Inc (ASX: 360)
Another ASX growth share to consider is location technology company Life360.
Life360 is transitioning from just a user growth story into a user growth and monetisation story. Its platform has almost 100 million users globally, but the focus is now on converting that scale into sustainable earnings.
Subscription growth, partnerships, and new features are helping drive revenue higher, while improving operating leverage is supporting profitability.
If the company continues executing well, it could evolve into a highly scalable global platform business.
Pro Medicus Ltd (ASX: PME)
A third ASX growth share that stands out is Pro Medicus.
Pro Medicus provides medical imaging software and has built a reputation for winning large, long-term contracts with leading hospitals.
What sets it apart is its high-margin business model and strong competitive positioning. Once its technology is in place, switching costs are high, leading to recurring revenue and strong retention.
ResMed Inc (ASX: RMD)
A fourth ASX growth share that could be worth considering is ResMed.
ResMed operates in the sleep apnoea and respiratory care market, combining medical devices with digital health platforms.
Its business benefits from recurring revenue, as patients continue to purchase masks, software, and accessories over time. There are also strong structural tailwinds, including ageing populations and increasing awareness of sleep health.
With ongoing innovation and a growing global footprint, ResMed appears well placed to deliver sustainable growth long into the future.
WiseTech Global Ltd (ASX: WTC)
A final ASX growth share that could be worth considering is WiseTech Global.
WiseTech is building the software backbone for global logistics through its CargoWise platform. Its solutions are deeply embedded in customer operations, creating strong switching costs and recurring revenue.
The company continues to expand its capabilities and increase its reach across global supply chains.
As trade becomes more complex and digitised, WiseTech's platform could become even more critical, supporting long-term growth.
